Groups for Regaining Our Wellbeing
GROW
Evaluation of a Mindfulness-Based Intervention for Gulf War Illness
1 other identifier
interventional
245
1 country
1
Brief Summary
This study is a randomized clinical trial measuring outcomes up to 6-months post-intervention. The objective of this study is to evaluate outcomes of two different group interventions for Veterans with Chronic Multisymptom Illness (CMI). The interventions to be compared are Mindfulness-Based Stress Reduction and an adapted version of the Chronic Disease Self-Management Program (aCDSMP) for Veterans experiencing symptoms of Chronic Multi-Symptom Illness (CMI) - musculoskeletal pain, fatigue, and cognitive failures - especially those who were deployed to Gulf War I. Hypothesis One (re: Outcomes): Participants randomized to the adapted Chronic Disease Self-Management Program (aCDSMP) will derive benefit for the primary outcomes, but with smaller effects than the participants randomized to Mindfulness-Based Stress Reduction (MBSR). The investigators hypothesize that Veterans randomized to MBSR will report greater reductions in each of the three primary outcome measures (pain, fatigue, and cognitive failures) at 6-month follow-up as compared to aCDSMP. Hypothesis Two (re: Acceptability): MBSR will be an acceptable and satisfactory program for Veterans with CMI, as measured by attendance rates, a self-report measure of satisfaction, and qualitative interviews. The investigators hypothesize that Veterans with CMI randomized to MBSR will report greater satisfaction with care than their peers randomized to aCDSMP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2017
CompletedFirst Posted
Study publicly available on registry
February 23, 2017
CompletedStudy Start
First participant enrolled
August 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2022
CompletedResults Posted
Study results publicly available
June 21, 2024
CompletedJune 21, 2024
February 1, 2024
4.6 years
February 7, 2017
May 25, 2023
February 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Short Form McGill Pain Questionnaire (SF-MPQ-2) Total Score
A validated measure of pain, minimum value: 0, maximum value: 222, higher scores indicate worse outcomes.
Change from baseline to 6 months after completing the intervention
General Fatigue Subscale of the Multidimensional Fatigue Inventory (MFI)
A measure of general fatigue symptoms. Minimum value: 0, maximum value: 80, higher scores indicate worse outcomes.
Change from baseline to 6 months after completing the intervention
Cognitive Failures Questionnaire (CFQ)
A measure of concentration and memory disturbances. Minimum value: 0, maximum value: 100, higher scores indicate worse outcomes.
Change from baseline to 6 months after completing the intervention
Client Satisfaction Questionnaire (CSQ-8)
A measure of satisfaction with the interventions. Minimum value: 8, maximum value: 32, higher scores indicate higher satisfaction.
report at post-intervention assessment, 3-4 months after baseline
Secondary Outcomes (4)
Patient Health Questionnaire (PHQ-9)
Change from baseline to 6 months after completing the intervention
PTSD Checklist - Civilian Version (PCL-C)
Change from baseline to 6 months after completing the intervention
SF-12, Standard (Mental and Physical Component Summary Scores)
Change from baseline to 6 months after completing the intervention
NIH Patient Reported Outcome Measures Information System (PROMIS) for Alcohol Negative Consequences, Short Form
Change from baseline to 6 months after completing the intervention
Study Arms (2)
Mindfulness-Based Stress Reduction
EXPERIMENTALAn 8-week standardized group program to teach mindfulness skills. In MBSR, participants meet for 2.5 hours per week for 8 weeks in a group format. Participants receive instruction in mindfulness meditation according to a standardized curriculum and have the opportunity to ask questions.
Chronic Disease Self-Management Program
ACTIVE COMPARATORThe CDSMP is a structured program to teach self-management skills based on self-efficacy theory. CDSMP teaches self-management strategies and attempts to modify illness beliefs, enhance self-management capabilities and reinforce successful management strategies. CDSMP is based on self-efficacy theory, which posits that key determinants of behavior are: 1). self-efficacy (confidence in the ability to carry out an action) and 2). outcome expectancy (expectation that a particular goal will be achieved).
Interventions
An 8-week standardized group program to teach mindfulness skills. In MBSR, participants meet for 2.5 hours per week for 8 weeks in a group format. Participants receive instruction in mindfulness meditation according to a standardized curriculum and have the opportunity to ask questions.
The CDSMP is a structured program to teach self-management skills based on self-efficacy theory. CDSMP teaches self-management strategies and attempts to modify illness beliefs, enhance self-management capabilities and reinforce successful management strategies. CDSMP is based on self-efficacy theory, which posits that key determinants of behavior are: 1). self-efficacy (confidence in the ability to carry out an action) and 2). outcome expectancy (expectation that a particular goal will be achieved).
Eligibility Criteria
You may qualify if:
- Self-report all the criteria for Chronic Multi-Symptom Illness
- Fluent in English and able to provide informed consent
You may not qualify if:
- Currently drinking with past-year history of alcohol-related seizures or delirium tremens
- Current DMS-V substance use disorder other than cannabis or nicotine
- Moderate or high risk of suicide as assessed with MINI
- Current psychotic disorder
- Current manic episode
- Diagnosis of borderline personality disorder or antisocial personality disorder
- Inpatient admittance for psychiatric reasons in the past month
- Prior participation in MBSR or CDSMP (attended at least one session)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Seattle, Washington, 98108, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Tracy Simpson
- Organization
- VA Puget Sound
Study Officials
- PRINCIPAL INVESTIGATOR
Tracy L Simpson, PhD
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2017
First Posted
February 23, 2017
Study Start
August 8, 2017
Primary Completion
March 31, 2022
Study Completion
May 31, 2022
Last Updated
June 21, 2024
Results First Posted
June 21, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
A de-identified, anonymized dataset will be created and shared. Only de-identified data, with no individually identifiable patient information, will be shared.